AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

barlowe charles


Dr. Barlowe studies intracellular trafficking and seeks to elucidate basic mechanisms that control protein and lipid transport through the early secretory pathway.  His research group investigates this process through a multidisciplinary approach that includes biochemistry, molecular genetics, proteomics and microcopy, primarily in the model organism Saccharomyces cerevisiae.  Roughly a quarter of translated proteins enter the secretory pathway at the endoplasmic reticulum (ER) where the coat protein complex II (COPII) selects folded secretory proteins into transport vesicles that bud from the ER for anterograde transport to the Golgi complex.  The Barlowe lab has identified and characterized novel membrane receptors that cycle between the ER-Golgi and are needed in concert with the COPII coat to select diverse sets of secretory cargo into ER-derived transport vesicles.  Current experimentation is focused on understanding how these membrane receptors recognize specific cargo and howcargo binding is regulated. His laboratory is also interested in defining the mechanisms that target and fuse COPII transport vesicles with the Golgi complex.

 

 

TPL_asm2013_SEARCH

91201